University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Gut microbiota in human type 2 diabetes : in-vivo and in-vitro studies.

Jaiyeola, Etana Joy (2017) Gut microbiota in human type 2 diabetes : in-vivo and in-vitro studies. Doctoral thesis, University of Surrey.

[img]
Preview
Text (Gut Microbiota In Human Type 2 Diabetes: In-vivo and In-vitro Studies)
Etana Jaiyeola Final Thesis.pdf - Version of Record
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB) | Preview

Abstract

The gut microbiota plays an important role in the development of type 2 diabetes (T2D), which is an alteration in the diversity and abundance of the gut microbiota, favouring the growth of Gram-negative bacteria. Although a lot of studies have shown this to be the case, most of this work has been done in animal models with few studies in humans. In animal models of T2D, it is known that a high-fat diet alters the gut microbiota in favour of the growth of Gram–negative bacteria. The outer membrane of Gram-negative bacteria contains lipopolysaccharide (LPS) which is an endotoxin that can trigger inflammation leading to metabolic disorders such insulin resistance and T2D, hence T2D is considered a low grade inflammatory disorder. In this thesis, the effect of Galactooligosaccharide (GOS), a prebiotic, on the composition of the gut microbiota was investigated. Next generation sequencing (NGS) of the gut microbiota of T2D and healthy control subjects showed no significant difference at the phylum level between the two groups. Furthermore, T2D patients in the prebiotic group had a significant increase in the level of Firmicutes compared to the placebo group. Also, although not significant, T2D patients on metformin had increased level of Bacteroidetes, Proteobacteria and Actinobacteria compared to those not on metformin. The ability of human faecal water (FW) to distinguish between healthy and T2D patients using an in vitro model of the intestinal mucosa was studied. FW from T2D patients decreased Caco-2 cell monolayer integrity when compared to the healthy controls and in the T2D patients, FW activity in vitro correlated with biological markers of T2D severity measured in vivo. Additionally, cytokines were measured in T2D faecal samples using a human cytokine array. Finally, GOS anti-cytotoxic activity was also assessed in vitro using cell viability assays and the anti-cytotoxic effect of GOS was time and concentration dependent. Together, the thesis explored potential new ways of using faecal samples as biomarker for T2D in vitro and relating it to in vivo parameters of the patients. Also future work in this area may reveal mechanistic insight to the use of FW as a non-invasive biomarker for T2D.

Item Type: Thesis (Doctoral)
Divisions : Theses
Authors :
NameEmailORCID
Jaiyeola, Etana JoyUNSPECIFIEDUNSPECIFIED
Date : 21 December 2017
Funders : Self, Schlumberger Faculty for the Future Award
Projects : European Funding for the Study of Diabetes
Contributors :
ContributionNameEmailORCID
http://www.loc.gov/loc.terms/relators/THSRobertson, MargaretM.Robertson@surrey.ac.ukUNSPECIFIED
http://www.loc.gov/loc.terms/relators/THSLa Ragione, RobertoR.Laragione@surrey.ac.ukUNSPECIFIED
Uncontrolled Keywords : Diabetes Type 2 Diabetes Gut Microbiota Feacal Water Feacea Intestinal permeability Bifidobacteria In-vitro In-vivo
Depositing User : Etana Joy Jaiyeola
Date Deposited : 08 Jan 2018 10:00
Last Modified : 08 Jan 2018 10:00
URI: http://epubs.surrey.ac.uk/id/eprint/844975

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800